Tag Archives: Evotec

May, 2018

  • 24 May

    Evotec and Celgene Enter into Strategic Oncology Partnership

    HAMBURG, Germany–(BUSINESS WIRE)–Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that Evotec and Celgene Corporation (“Celgene”) have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology. Evotec has built one of the industry’s broadest and most innovative pre-clinical discovery and …

October, 2017

  • 27 October

    Evotec and Tesaro Partner to Discover Novel Immuno-Oncology Agents

    HAMBURG, Germany–(BUSINESS WIRE)–Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and TESARO, Inc. (“TESARO”) today announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed immuno-oncology (IO) target. Under the terms of the collaboration, Evotec will apply its integrated drug …

December, 2016

March, 2015

  • 23 March

    Sanofi and Evotec Sign Long-Term Drug Discovery Deal

    Sanofi has signed a multi-component strategic agreement with Evotec over the next five years. The companies announced a definitive agreement for a major multi-component strategic alliance, successfully concluding the exclusive negotiations for a major multi-component strategic collaboration which the two companies entered into on December 2, 2014. The transaction, which …